Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02403323
Brief Title: Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

First Submitted : March 26, 2015
First Submitted that Met QC Criteria : March 26, 2015
First Posted : March 31, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 29, 2019
Last Update Posted : May 1, 2019